BRCA1 and cancer: In women carrying a germline pathogenic variant in BRCA1/2, there are several risk management strategies recognized as effective and cost-effective to mitigate the increased cancer risk, such as Risk-reducing salpingo-oophorectomy for the prevention of OC [25].